Dr. Balaji Prasad is the Chief Strategy Officer at Alvotech. A medical doctor by training, Dr. Prasad has 25 years of experience in the pharmaceutical industry, first as a consultant and subsequently as a financial and equities analyst focused on the specialty pharma and healthcare sectors. Prior to joining Alvotech, he was a director and highly ranked equities analyst at Barclays, covering U.S. specialty pharma. Previously, he served as portfolio manager at a Swiss asset management firm focusing on global specialty pharma and generics and led Barclays’ and Goldman Sachs’ India healthcare coverage from Mumbai.

Dr. Prasad earned his MD from Bangalore Medical College and his MBA from IIM Ahmedabad.